MEDBOX | Category Communicable Diseases

Communicable Diseases

Advanced search

Create your MEDBOX

Communicable Diseases

Advanced search

Create your MEDBOX

Go back

Sub-Categories

Vaccine-preventable Diseases

Diarrhoeal Disease/Cholera

OUR RECOMMENDATIONS

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV (2022)

Updated recommendations on treatment of adolescents and children with chronic HCV infection (2022)

Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection (2022)

Clinical management and infection prevention and control for monkeypox (2022)

Affenpocken: Verdachtsabklärung und Maßnahmen, Orientierungshilfe für Ärztinnen und Ärzte (2022)

NEW

NEW

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV (2022)

Updated recommendations on treatment of adolescents and children with chronic HCV infection (2022)

Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection (2022)

Monkeypox and pregnancy: what do obstetricians need to know? (2022)

Global clinical data platform for severe acute hepatitis of unknown aetiology in children case report form (CRF) (2022)

LIST OPTIONS

FILTER BY LANGUAGE

FILTER BY COUNTRY

SORT BY

RESULTS/PAGE

LIST TYPE

448 records

	Guidelines for the treatment of drug-susceptible tuberculosis and patient care, 2017 up-date H. Schünemann, S.T. Aung, F. Bonsu et al. World Health Organisation (WHO) (2017) C_WHO View PDF(1115) Download (730) Add to my MEDBOX Tags: MDR-TB, Multi-drugresistant Tuberculosis/MDR-TB, Multidrug resistant tuberculosis, TB drugs, tb treatment, Source: http://apps.who.int/iris/bitstream/10665
	EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection European Association for the Study of the Liver (2017) CC Open external link (2023) Add to my MEDBOX J Hepatol (2017), http://dx.doi.org/10.1016/j.jhep.2017.03.021 Tags: hepatitis B, clinical management, Clinical Guidelines, clinical practice guidelines, Europe, Source: https://www.easl.eu/medias/cpg/managemen
	Major Infectious Diseases. Disease Control Priorities, Third Edition : Volume 6 Holmes, King K.; Bertozzi, Stefano; Bloom, Barry R.; Jha, Prabhat World Bank (2017) CC Open external link (1398) Add to my MEDBOX Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings. Large File: 136 MB!!!!! Please download from the website link Tags: HIV, HIV/TB, TB, HIV/AIDS, STI, STD, NTD, Hepatitis, malaria, febrile illness, Source: https://openknowledge.worldbank.org/hand
	Guidelines on hepatitis B and C testing World Health Organization (WHO) (2017) C_WHO View PDF(1305) Download (577) Add to my MEDBOX Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviours and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination Tags: Testing, laboratory, diagnostics, hepatitis B, hepatitis C, Hepatitis, Source: http://apps.who.int/iris/bitstream/10665
	Guidelines on hepatitis B and C testing. Policy brief World Health Organization (WHO) (2017) C_WHO View PDF(1000) Download (433) Add to my MEDBOX Tags: Hepatitis, hepatitis C, hepatitis B, Guidelines, Testing, diagnostics, Source: http://apps.who.int/iris/bitstream/10665
	WHO bes -practice statement on the off -label use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis World Health Organization WHO (2017) C_WHO View PDF(983) Download (375) Add to my MEDBOX Tags: Multidrug resistant tuberculosis, Bedaquiline, Antimicrobial resistance, Source: http://apps.who.int/iris/bitstream/10665
	Surveillance of HIV drug resistance in children newly diagnosed with HIV by early infant diagnosis. Concepte Note World Health Organization WHO (2017) C_WHO View PDF(678) Download (404) Add to my MEDBOX This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month perio Tags: Children, HIV, hiv drug resistance, hiv drugs, ART, ART drugs, ARV, ART therapy, vertical transmission/PMTCT, PMTCT, Surveillance, Source: http://apps.who.int/iris/bitstream/10665
	Interim National Guidelines for Monkeypox Outbreak Response Federal Ministry of Health - Nigeria Centre for Disease Contro (2017) C2 View PDF(520) Download (270) Add to my MEDBOX This document provides information and recommendations for action, based on the current available knowledge around monkeypox. It is a first draft which will be updated in light of evolving evidence and additional information as they become available Tags: Suspected Monkeypox Outbreak Alert, monkeypox, Nigeria, Guidelines, transmission, signs and symptoms, diagnosis, Prevention, Outbreak Control, Surveillance, Infection Prevention and Control (IPC), Source: http://www.ncdc.gov.ng/themes/common/doc
	WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update Dennis Falzon, Elizabeth Harausz, Ernesto Jaramillo et al. World Health Organization (WHO) (2016) C_WHO View PDF(2482) Download (1088) Add to my MEDBOX Tags: Multi-drugresistant Tuberculosis/MDR-TB, MDR-TB, Treatment, TB drugs, TB control, Source: https://www.ncbi.nlm.nih.gov/books/n/who
	Handbook on TB laboratory diagnostic methods in the European Union European Centre for Disease Prevention and Control (2016) C1 Open external link (1436) Add to my MEDBOX The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent TB infection. This handbook offers a single source of reference by compiling all methods, with a strong focus on standard (reference) and evidence-based methods. In so doing, it will also contribute to the improvement of disease surveillance data for Europe. Tags: Tuberculosis, tb diagnostic, Europe, Laboratory diagnostics, Source: http://ecdc.europa.eu/en/publications/Pu

448 records

448 records